Novo Nordisk A/S

A view shows The World Health Organization (WHO) headquarters in Geneva, Switzerland, Jan. 28, 2025. Denis Balibouse |…

In the battle between weight-loss drug companies, Eli Lilly has emerged as the clear winner for investors. The…

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024.…

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…

The city of Lisbon in Portugal turns to tech next week, as it plays host to the annual…

US President Donald Trump makes an announcement in the Oval Office of the White House in Washington, DC…

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg |…

Bagsværd, 5 November, 2025 – Financial report for the period 1 January 2025 to 30 September 2025 …

The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…

A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…

Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…

WHO backs use of GLP-1 therapies for obesity, warns access will remain limited